Most genes in higher eukaryotes are transcribed as premRNAs that contain intervening sequences (introns), as well as expressed sequences (exons). Discovered in the late 1970s, introns are now known to be removed during the process of pre-mRNA splicing, which joins exons together to produce mature mRNAs 1,2 . Because most human genes contain multiple introns, splicing is a crucial step in gene expression. Although the splicing reaction is chemically simple, what occurs inside a cell is much more complicated: splicing is catalysed in two distinct steps by a dynamic ribonucleoprotein (RNP) machine called the spliceosome 3 , requiring hydrolysis of a large quantity of ATP 4 . This increased complexity is thought to ensure that splicing is accurate and regulated.
Most genes in higher eukaryotes are transcribed as premRNAs that contain intervening sequences (introns), as well as expressed sequences (exons). Discovered in the late 1970s, introns are now known to be removed during the process of pre-mRNA splicing, which joins exons together to produce mature mRNAs 1, 2 . Because most human genes contain multiple introns, splicing is a crucial step in gene expression. Although the splicing reaction is chemically simple, what occurs inside a cell is much more complicated: splicing is catalysed in two distinct steps by a dynamic ribonucleoprotein (RNP) machine called the spliceosome 3 , requiring hydrolysis of a large quantity of ATP 4 . This increased complexity is thought to ensure that splicing is accurate and regulated.
The spliceosome is composed of five different RNP subunits, along with many associated protein co factors 4, 5 . To distinguish them from other cellular RNPs, such as ribosomal subunits, the spliceosomal subunits were termed small nuclear RNPs (snRNPs). As with ribosome assembly, the biogenesis of spliceosomal snRNPs is a multistep process that takes place in distinct subcellular compartments. A common principle in the biogenesis of snRNPs is the assembly of stable, but inactive, pre-RNPs that require maturation at locations that are distinct from their sites of function. Assembly of functional complexes and delivery to their final destinations are often regulated by progression through a series of intermediate complexes and subcellular locales.
In this Review, we discuss the key steps in the life cycle of spliceosomal snRNPs. We focus on how small nuclear RNAs (snRNAs) are synthesized and assembled with proteins into RNPs and, furthermore, how the snRNPs are assembled into the spliceosome. Finally, we highlight our current knowledge of regulatory proteins and how they affect snRNP function. We draw on recent insights from molecular, genetic, genomic and ultrastructural studies to illustrate how these factors ultimately dictate splice site choice.
Biogenesis of spliceosomal RNPs
The snRNAs are a group of abundant, non-coding, nonpolyadenylated transcripts that carry out their functions in the nucleoplasm. On the basis of common sequence features and protein cofactors, they can be subdivided into two major classes: Sm and Sm-like snRNAs 6 . Below, we focus on the biogenesis and processing of the major and minor Sm-class spliceosomal snRNAs: U1, U2, U4, U4atac, U5, U11 and U12. Biogenesis of the Sm-like snRNA s (U6 and U6atac) is distinct from that of Sm-class RNAs 6 and is not discussed in detail here.
Transcription and processing of snRNAs. In metazoans, transcription and processing of snRNAs are coupled by a cellular system that is parallel to, but distinct from, the one that generates mRNAs. Indeed, snRNA genes share many common features with protein-coding genes, including the relative positioning of elements that control transcription and RNA processing (FIG. 1) . Sm-class snRNAs are transcribed from highly specialized RNA polymerase II (Pol II) promoters that contain proximal and distal sequence elements similar to the TATA box and enhancer sequences, respectively, of protein-coding genes. In addition to the general transcription factors
Splice site
The short sequences at exonintron junctions of pre-mRNA, which include the 5ʹ splice (splice donor) site and the 3ʹ splice (splice acceptor) site located at the beginning and the end of an intron, respectively.
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. Specific post-translational modifications of the carboxy-terminal domain (CTD) of the Pol II large subunit are important for loading these processing factors and for accurate processing 10, 11 . Similar to other Pol II transcripts, capping of the 5ʹ end of an snRNA and cleavage of its 3ʹ end are thought to occur co-transcriptionally (FIG. 1) .
Maturation of the snRNA 3ʹ end requires a large, multisubunit factor called the integrator complex 12, 13 , which recognizes a downstream processing signal (called the 3ʹ-box) and endonucleolytically cleaves the nascent transcript as it emerges from the polymerase (FIG. 1) . Whether this cleavage occurs before, or concomitant with, the arrival of Pol II at the downstream terminator sequence is not known. Interestingly, integrator sub unit 11 (INTS11) and INTS9 share important sequence similarities to components of the mRNA 3ʹ end-processing machinery, cleavage and polyadenylation specificity factor 73 kDa subunit (CPSF73) and CPSF100, respectively 12, 14, 15 . However, beyond these two subunits, the integrator complex proteins bear little similarity to those involved in mRNA cleavage and polyadenylation 13, 16 . Notably, the cyclin-dependent kinase 8 (Cdk8)-cycli n C heterodimer shows snRNA 3ʹ-processing activity in a reporter assay and physically associates with the integrator complex 13 . Although the kinase activity of Cdk8-cyclin C is also essential for processing, whether it phosphorylates integrator subunits and/or the Pol II CTD remains unclear 13 .
Thus, the precise mechanism by which metazoan Pol II snRNA gene transcription is terminated remains mysterious. What is clear is that 3ʹ-end processing of Sm-class snRNAs requires three important features: an snRNAspecific promoter, a cis-acting 3ʹ-box element located downstream of the cleavage site and an assortment of trans-acting factors that load onto the Pol II CTD (FIG. 1) .
Nuclear export, Cajal bodies and RNP quality control. Sm-class snRNPs primarily function in the nucleus. However, in most species, newly synthesized snRNAs are first exported to the cytoplasm, where they undergo additional maturation steps before they are imported back into the nucleus. Notable exceptions to this rule are found in budding yeast and trypanosomes, in which RNP assembly is thought to be entirely nuclear [17] [18] [19] [20] [21] . Why cells export precursor snRNAs to the cytoplasm only to re-import them after their assembly into stable RNP particles is not known. This property is not unique to snRNAs: ribosomal subunits, which function in the cytoplasm, are primarily assembled in the nucleolus 22 . Both types of RNP certainly undergo remodelling steps within their 'destination' compartments, but the initial stages of particle assembly take place in remote cellular locations. This arrangement provides a plausible mechanism for quality control, ensuring that partially assembled RNPs do not come into contact with their substrates.
Most types of RNA, including ribosomal RNA, tRNA, mRNA, microRNA (miRNA) and signal recognition particle (SRP) RNA, are exported to the cytoplasm following nuclear transcription and processing. Emerging evidence points to a role for nuclear RNA-binding factors in specifying the cytoplasmic fate of RNAs 23 . However, the connections between RNA processing and nuclear export are not as well worked out as they are for transcription and 3ʹ-end formation. Typically, specific RNA sequences and/ or structures are the determinants that promote direct or indirect binding to the appropriate transport receptor (as occurs for tRNAs and rRNAs) 24 . Because Sm-class snRNAs and mRNAs are both transcribed by Pol II, they share a 5ʹ-cap structure, raising the issue of how the export machinery discriminates between these two types of RNA. Solving this long-standing riddle, an elegant series of papers has shown that snRNAs are distinguished from mRNAs on the basis of their length and their association with heterogeneous nuclear RNP (hnRNP) C1-C2 proteins [25] [26] [27] [28] . Pol II mRNA transcripts that are Sm-class small nuclear RNA (snRNA) genes (part a) share several common features with protein-coding mRNA genes (part b), including the arrangement of upstream and downstream control elements. The cis-acting elements and trans-acting factors involved in the expression of these two types of transcripts are depicted. The distal sequence element (DSE) and proximal sequence element (PSE) are roughly equivalent to the enhancer and TATA box elements, respectively, of mRNA genes. Positive transcription elongation factor b (P-TEFb; not shown) is recruited to both promoters by RNA polymerase II (Pol II). In addition, snRNA promoters recruit the little elongation complex (LEC), whereas mRNA promoters recruit the super elongation complex (SEC) 202 . Initiation of snRNA transcription requires general transcription factors (GTFs), as well as the snRNA-activating protein complex (SNAPc). The integrator complex is required for recognition of snRNA downstream processing signals, including the 3ʹ box. Integrator subunit 11 (INTS11) and INTS9 have sequence similarities to the mRNA 3ʹ-processing factors cleavage and polyadenylation specificity factor 73 kDa subunit (CPSF73) and CPSF100, respectively. For both snRNAs and mRNAs, 5ʹ-end capping and 3ʹ-end cleavage are thought to occur co-transcriptionally. Additional processing factors (not shown) are recruited to the nascent transcripts via interactions with the Pol II carboxy-terminal domain. Ex, exon; pA, polyA signal; ss, splice site; TSS, transcription start site.
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Pre-import complex longer than ~250 nucleotides are bound by hnRNP C1-C2 tetramers and shunted towards the nuclear RNA export factor 1-NTF2-related export 1 (NXF1-NXT1; also known as TAP-p15) mRNA export pathway 28 . Transcripts shorter than this threshold are exported by a distinct set of factors that includes the cap-binding complex (cap-binding protein 80 kDa (CBP80; also known as NCBP1) and CBP20 (also known as NCBP2)) 29 , the snRNA-specific export adaptor phosphorylated adapter RNA export (PHAX) 30 and arsenite resistance 2 (ARS2; also known as SRRT) 31 . These proteins form a link between the 5ʹ cap and the export receptor chromosome region maintenance 1 (CRM1; also known as exportin 1), which interacts with nuclear pore proteins to promote export 32 (FIG. 2) . Although PHAX can bind to mRNA 5ʹ caps in vitro, it is inhibited from doing so in vivo by hnRNP C1-C2 (REF. 28 ).
Several lines of evidence indicate that precursor snRNA transcripts often traffic through snRNP-rich nuclear structures known as Cajal bodies on their way out of the nucleus. First, in situ hybridization shows that pre-snRNA transcripts with long 3ʹ extensions localize to mammalian Cajal bodies 33 . Second, microinjection experiments in Xenopus laevis oocyte nuclei reveal that pre-snRNAs temporarily accumulate in Cajal bodies, and that this localization decreases over time as the RNAs are exported 34 . Third, PHAX and CRM1 are concentrated in Cajal bodies 35, 36 . Fourth, inhibition of PHAX activity interferes with snRNA export 30 and has been shown to cause pre-snRNAs to accumulate within frog oocyte Cajal bodies 34 , as well as to result in dispersal of mammalian Cajal body components 37 . The data are most consistent with a model in which the assembly of pre-export complexes is facilitated within Cajal bodies and is followed by nuclear export on docking to CRM1. The model further invokes a function for Cajal bodies in nuclear RNP remodelling 38 and sorting 23 , as outlined below.
Cytoplasmic RNP assembly and the SMN complex. After the pre-snRNA translocates to the cytoplasm, dissociation of the export complex (FIG. 2) is triggered by dephosphorylation of PHAX 39 . The survival motor neuron (SMN) protein complex, which includes SMN and several tightly associated proteins, collectively called GEMINs [40] [41] [42] [43] [44] , is thought to regulate the entire cytoplasmic phase of the snRNP cycle. The SMN complex recruits the newly exported snRNAs and combines them with a set of seven Sm proteins to form a toroidal ring around an RNA-binding site that is present within each of the eponymous Sm-class snRNAs (FIG. 3) . The Sm proteins are delivered to the SMN complex via the activity of the protein Arg N-methyltransferase 5 (PRMT5) complex, which methylates C-terminal arginine residues within SmB, SmD1 and SmD3 (REFS 45, 46) and then chaperones delivery of partially assembled Sm subcomplexes 47, 48 . Binding to the SMN complex is therefore proposed to initiate in the cytoplasm, and GEMIN5 is thought to be the factor responsible for recognition of Sm site-containing RNAs 49 . Assembly of the Sm core not only stabilizes the snRNA by protecting it from nucleases Figure 2 | Maturation of snRNAs requires nuclear and cytoplasmic regulatory steps. The small nuclear RNA (snRNA) pre-export complex consists of the heterodimeric cap-binding complex (CBC), arsenite resistance protein 2 (ARS2), the hyperphosphorylated (P) form of the export adaptor phosphorylated adapter RNA export (PHAX) and the large multisubunit integrator complex (not shown). On release from the site of snRNA transcription, the pre-export complex is remodelled within the nucleoplasm to form the export complex. This step involves the removal of integrator proteins and the binding of the export receptor chromosome region maintenance 1 (CRM1) and the GTP-bound form of the RAN GTPase. Nucleoplasmic remodelling probably includes a Cajal body-mediated surveillance step to ensure ribonucleoprotein (RNP) quality. When transported to the cytoplasm, these export factors dissociate from the pre-snRNA prior to Sm core assembly and exonucleolytic trimming of the snRNA 3ʹ end (shown by the stem-loop in orange). Following assembly of the Sm core small nuclear RNP (snRNP; detailed in FIG. 3) , the 7-methylguanosine (m 7 G) cap is hypermethylated by trimethylguanosine synthase 1 (TGS1) to form a 2,2,7-trimethylguanosine (TMG) cap. Generation of the TMG cap triggers assembly of the import complex, which includes the import adaptor Snurportin (SPN) and the import receptor importin-β; both SPN and the survival motor neuron (SMN) complex make functional contacts with importin-β (for simplicity, other components of the SMN complex are not depicted). On nuclear re-entry, the Sm snRNPs transiently localize to Cajal bodies for nuclear maturation steps, followed by dissociation from SMN and storage within splicing factor compartments called nuclear speckles. Spliceosome assembly (detailed in FIG. 4 ) takes place at sites of pre-mRNA transcription. NPC, nuclear pore complex. Nature Reviews | Molecular Cell Biology 
Tudor domain
A conserved protein structural motif that is thought to bind to methylated arginine or lysine residues, promoting physical interactions with its target protein.
but also is required for the downstream RNA-processing steps that culminate in nuclear import. The physiological relevance of Sm core assembly has also been emphasized by the demonstration that mutations in the gene encoding the SMN protein cause the human neuromuscular disease spinal muscular atrophy
. Sm proteins do not bind the snRNA as a pre-formed ring. Instead, they form heterodimeric (SmD1-SmD2 and SmB-SmD3) or heterotrimeric (SmE-SmF-SmG) subcomplexes (FIG. 3) . When purified in vitro, these subcomplexes spontaneously coalesce into a ring only in the presence of an appropriate RNA target [50] [51] [52] . However, in cell extracts, this reaction requires the whole SMN complex as well as ATP 40 . In vivo, the SMN complex is thus thought to provide added specificity, to avoid assembly of Sm cores onto non-target RNAs 41, 49 and to accelerate formation of the final product from kinetically trapped intermediates 48 . One of the most surprising insights from recent studies of the SMN complex is that the SMN protein is probably not the primary architect of Sm core RNP assembly. Two crystallographic studies demonstrated that GEMIN2, a conserved member of the SMN complex 53 , binds directly to five of the seven Sm proteins (FIG. 3) and holds them in the proper 'horseshoe' orientation for subsequent snRNA binding and ring closure 54 . These results were not predicted from earlier in vitro binding studies of GEMIN2 (REF. 55 ) and were surprising because previous work on Sm binding had mainly focused on SMN itself 56,57 . However, given that the budding yeast genome apparently lacks SMN but contains a potential GEMIN2 orthologue 55,58 , the idea that GEMIN2 has a starring role in Sm core assembly is gaining considerable traction.
Precisely how SMN is involved in Sm core RNP formation is still open to debate, although RNAi analyses in metazoan cells have demonstrated that it is required 59, 60 . Moreover, SMN-GEMIN2 heterodimers are sufficient for Sm core assembly activity in vitro 53 . Importantly, the assembly chaperone pICln (also known as CLNS1A) (FIG. 3) may function as an SmB-SmD3 mimic that stabilizes the pentameric Sm horseshoe structure in preparation for handover to GEMIN2 (REFS 47, 48) . The Tudor domain of SMN contains an Sm-fold 61 and is hypothesized to have a When formed, the 6S complex of the Sm pentamer (D1-D2-F-E-G) and pICln is thought to be released from the PRMT5 complex as a separate particle. This 6S complex is delivered to the oligomeric, multisubunit survival motor neuron (SMN) complex, which provides the overall platform for subsequent assembly steps. GEMIN2, the heterodimeric binding partner of SMN, binds to the 6S complex, forming an early 8S assembly intermediate. In parallel, the SMN complex including GEMIN5 recognizes specific sequence elements (the Sm-site and the 3ʹ stem-loop) within the post-export small nuclear RNA (snRNA). A poorly understood series of rearrangements leads to the formation of the assembled core small nuclear ribonucleoprotein (snRNP). These involve recruitment of the 7-methylguanosine (m 7 G)-capped snRNA and the SmB-SmD3-pICln subcomplex (via an unknown mechanism; represented by the question mark), followed by dissociation of pICln. Prior to SmB-SmD3 incorporation, the 'horseshoe' intermediate may be stabilized by the Tudor domain of SMN, which contains an Sm fold. Incorporation of SmB-SmD3 and completion of the heteroheptameric ring requires the presence of an RNA that contains an Sm site. This produces an assembled core snRNP that is ready for downstream events including 2,2,7-trimethylguanosine (TMG) capping and formation of the nuclear import complex (FIG. 2) . The entire process of Sm core assembly and formation of the pre-import complex is carried out within the context of the SMN complex (violet rectangle).
Nuclear speckles
Sub-nuclear structures highly enriched in pre-mRNA-splicing factors. At the ultrastructural level, they correspond to domains known as interchromatin granule clusters.
SR proteins
Proteins that contain a domain with repeats of serine (S) and arginine (R) residues and one or more RNA-recognition motifs. SR proteins are best known for their ability to bind exonic splicing enhancers and activate splicing, although some SR proteins also regulate transcription.
mimetic role (FIG. 3) , occupying the space for SmB-SmD3 during the transition between the pICln-bound intermediate and the GEMIN2-Sm pentamer structure 47 . The self-oligomerization activity of SMN, contained within its C-terminal YG-box domain, is also required for Sm core formation 57, 60, 62 . It is not yet clear how the C terminus of SMN, which forms a YG-zipper motif 63 , interfaces with the rest of the SMN molecule and other members of the SMN complex. These and other important factors will need to be addressed by future studies.
Nuclear import and RNP remodelling. Formation of the Sm ring protects and stabilizes the snRNA and initiates downstream RNA-processing steps that culminate in nuclear import of the SMN complex (FIG. 2) . As part of its overall chaperoning function, the SMN complex recruits trimethylguanosine synthase 1 (TGS1), an RNA methyl transferase that modifies the snRNA 5ʹ end to form a 2,2,7-trimethylguanosine (TMG) structure 44 .
The TMG cap functions as a nuclear-localization signal 64 . Along with a subset of factors within the SMN complex 65 , the Sm core itself functions as a second, parallel nuclear-localization signal 66 . Concomitant with (or subsequent to) these 5ʹ events, the 3ʹ end of the snRNA is exo nucleolytically trimmed to its mature length. Thus, SMN-mediated assembly of the Sm core is required for proper cytoplasmic RNP maturation in vivo.
After import back into the nucleus, TMG cap formation triggers dissociation of TGS1 from the preimport complex (FIG. 2) ; this is followed by binding of Snurportin 67 , the snRNP-specific import adaptor, to the hypermethylated cap structure. Snurportin interacts directly with the import receptor importin-β 68 to promote import, although the SMN complex (or a subcomplex thereof) is also thought to accompany newly assembled snRNPs into the nucleus 65 . The SMN complex does not associate with nucleus-injected (that is, 'naked') RNAs; experiments in X. laevis oocyte nuclei showed that the SMN complex interacts with microinjected snRNA s only after their export to the cytoplasm 69 .
When an snRNP has been imported into the nucleus, it is free to diffuse throughout the interchromatin space. SMN is thought to dissociate from the snRNP fairly soon after import, as the protein does not co-purify with mature snRNP mono-particles, spliceosomes or splicing intermediates [70] [71] [72] . In most cell types, the nuclear fraction of the SMN complex localizes primarily within Cajal bodies; however, SMN also accumulates in distinct nuclear substructures called Gemini bodies (Gems) 73 . Cajal bodies contain a plethora of RNAs and their associated proteins, but components of Gems have thus far been limited to consituents of the SMN complex 73, 74 . In mammalian cells, substantial evidence points to a role for Cajal bodies in the nucleoplasmic maturation of snRNPs following nuclear import. Newly imported Sm-class RNPs transiently accumulate in Cajal bodies before localizing in other nucleoplasmic subcompartments known as nuclear speckles (see below) 75, 76 . In nuclear transport assays using digitonin-permeabilized cells, Snurportin 1 and partially assembled (12S) U2 snRNPs accumulate in Cajal bodies 77 . Additional RNPremodelling and RNA-processing steps are thought to take place in Cajal bodies, including non-coding RNAguided covalent modification of the snRNAs 78 and binding of snRNP-specific proteins 79, 80 . Furthermore, Cajal bodies are thought to facilitate the de novo assembly and post-splicing reassembly of U4-U6 di-snRNP and U4-U6•U5 tri-snRNP [81] [82] [83] . Given that Cajal body homeostasis is disrupted by depletion of various snRNP biogenesis factors 37, 60, 84, 85 , it is perhaps surprising that snRNP trafficking through Cajal bodies is not obligatory in mice or flies [86] [87] [88] (although it seems to be essential in fish 89 ). Taken together, these findings strongly suggest that Cajal bodies participate in RNP biogenesis on both the outbound and inbound legs of the journey of an snRNA through the cell.
Within the nucleus, spliceosomal snRNPs and their associated cofactors (for example, SR proteins) are typically excluded from nucleoli, localizing in a punctate pattern of variably sized and irregularly
Box 1 | Human spliceosomal diseases
Splicing is a major regulatory step in gene expression, and mis-regulation of splicing is a common feature of many human diseases. These disorders can be caused by mutations that disrupt the splicing of specific genes 173, 174 or by a general loss of spliceosomal function, affecting many gene targets. We focus here on those that disrupt spliceosomal biogenesis and/or function.
Retinitis pigmentosa is an inherited degenerative eye disease that causes severe vision impairment and blindness. Mutations in several core spliceosomal proteins (for example, pre-mRNA-splicing factor 3 (PRPF3), PRPF8, PRPF31, phosphatidic acid phosphohydrolase 1 (PAP1), and the human homologues of pre-mRNA-processing 8 (Prp8) and Brr2) cause autosomal-dominant retinitis pigmentosa 17, [175] [176] [177] , suggesting that human retinal cells are especially sensitive to splicing defects. Mutations in the minor spliceosomal small nuclear RNA (snRNA) U4atac were recently shown to result in microcephalic osteodysplastic primordial dwarfism (MOPD) type I 178 , a rare genetic defect that causes severe growth retardation and infant death.
Spinal muscular atrophy (SMA) is a recessive neuromuscular disease caused by reduced levels of the survival motor neuron (SMN) protein. There are two SMN genes in humans, SMN1 and SMN2. SMA is usually caused by homozygous deletion of SMN1. Owing to a single point mutation between the two paralogues, exon 7 of SMN2 is often skipped, resulting in a truncated and unstable protein product 179 . Consistent with the primary function of SMN in the biogenesis of spliceosomal small nuclear ribonucleoproteins (snRNPs), complete loss of SMN function is embryonic lethal 180 . However, it remains unclear why partial loss of SMN function causes a neuromuscular disease. Although animal models of severe SMA show differential reduction in the levels of major versus minor Sm-class snRNPs 181 , recent reports dispute the extent to which defects in minor intron splicing can account for SMA-like phenotypes 182, 183 .
Using an SMN point mutation that causes a mild-intermediate form of SMA in humans, it was shown that the role of SMN in snRNP biogenesis can be uncoupled from the organismal viability and locomotor defects 182 . Thus, although splicing defects are a predominant feature of severe SMA, they are detectable only relatively late in the disease course, well after the onset of neuromuscular deficits 184 , and a better understanding of SMA disease aetiology is still required.
Chronic lymphocytic leukaemia and myelodysplasia have also been associated with splicing defects 185, 186 . For example, core components of the U2 snRNP, such as splicing factor 3B subunit 1 (SF3B1) and U2 auxiliary factor 35 (U2AF35), are frequently mutated in these cancers 185, 186 . Such mutations might result in defective snRNP assembly, deregulated alternative splicing or accumulation of unspliced mRNA, and thus may alter the expression of multiple genes 187 . In addition to genetic mutations, the mis-regulation of splicing factor levels has often been found to be associated with various neoplasias 186 . Such a shift in expression level for major splicing factors in cancers may explain the extensive change of alternative splicing that is observed for thousands of genes in samples from patients with cancer. Therefore, targeting spliceosome function may provide a new route for cancer therapy.
Branch point
A loosely conserved short sequence usually located ~15-50 nucleotides upstream of the 3ʹ splice site, before a region rich in pyrimidines (cytosine and uracil). Most branch points include an adenine nucleotide as the site of lariat formation.
Exon definition
One of two different modes of initial splice site pairing at the early stage of splicing (the other being intron definition). During exon definition, the U1 and U2 small nuclear ribonucleoproteins (snRNPs) interact to pair the splice sites across an exon. For some small introns, the U1 and U2 snRNPs interact to pair the splice sites across introns.
shaped nuclear speckles. In fact, this speckled pattern is highly diagnostic for factors involved in premRNA splicing 76 . Speckles are extremely dynamic nucleoplasmic domains but contain little or no DNA and are thus thought to function as storage compartments 90 . Most splicing activity seems to localize to the borders between speckles and the adjacent chromatin domains 91, 92 . Precisely how snRNPs and other splicing factors are recruited from the speckles to sites of active transcription is unclear. However, when the fully assembled snRNPs are loaded onto the Pol II CTD and targeted to the site of transcription, they are then poised to carry out spliceosome assembly and pre-mRNA splicing.
Spliceosomal assembly and catalysis
Non-coding RNAs typically function as adaptors that position nucleic acid targets adjacent to an enzymatic activity that is catalysed either by the RNAs themselves or by associated proteins 6 . Consistent with this idea, spliceosomal snRNA function is driven by base pairing with short conserved motifs located at the junctions between the expressed exon sequences and the intervening introns of target mRNAs. The 5ʹ splice site (5ʹss) of a pre-mRNA is present at the beginning of an intron, the 3ʹss is located at the end of an intron and the branch point adenosine is usually located ~15-50 nucleo tides upstream of the 3ʹss (FIG. 1b) . In addition to being controlled by the primary splicing signals located at exon-intron boundaries, splice site choice is modulated by multiple cis-acting regulatory elements throughout the pre-mRNA. As outlined below, spliceo somes are assembled on their targets by a multistep process in which these cis-acting elements recruit trans-acting factors that ultimately control higher order particle assembly. For more details on splicing mechanism s, readers are referred to recent reviews 4, 93 .
Stepwise spliceosome assembly. Although spliceosome assembly is best-understood in budding yeast, the key assembly steps are well conserved in humans. For the purposes of this Review, we refer to the names of yeast proteins. First, U1 snRNP recognizes the 5ʹss via base pairing of U1 snRNA to the mRNA, forming the early complex (complex E (FIG. 4a) ). In addition to recognition by base pairing, the 5ʹss can be recognized by U1C, a subunit of the U1 snRNP 94 . This process is facilitated by the Pol II CTD, which reportedly interacts directly with U1 snRNP 95, 96 , although the functional role of this interaction is still under debate 97 . The interaction between the 5ʹss and U1 snRNP in complex E is ATPindependent and fairly weak; it is stabilized by other factors, such as by SR proteins 98, 99 and the cap-binding complex 100 . The 3ʹss of the pre-mRNA is recognized by the U2 snRNP and associated factors, such as splicing factor 1 (SF1) and U2 auxiliary factors (U2AFs), which are also components of complex E.
In a subsequent ATP-dependent process catalysed by the DExD/H helicases pre-mRNA-processing 5 (Prp5) and Sub2, U2 snRNA recognizes sequences around the branch point adenosine and interacts with U1 snRNP to form the pre-spliceosome (complex A). Formation of an intron-spanning complex A was originally described in yeast, but more complicated assembly pathways are prevalent among higher eukaryotes. Because metazoan genes contain relatively short exons (~50-250 nucleotides) that are separated by larger introns (up to 1,000 kb), splice sites are predominantly recognized in pairs across exons through the interaction of U1 and U2 snRNPs 101, 102 . This process is called exon definition, and the U1-U2 snRNP complex that forms across exons is known as the exon definition complex 103 . In a subsequent transition step, U1 and U2 snRNPs undergo poorly understood re arrangements, forming an intron-spanning interaction known as the intron definition complex; this also brings the 5ʹss, branch point and 3ʹss into close proximity 104 . Thus, the metazoan intron definition complex is generally considered to be the equivalent of complex A in yeast, whereas the metazoan exon definition complex is similar to complex E.
Formation of the exon definition complex and the subsequent transition to the intron definition complex are intermediate stages that are crucial for regulating splicing 105, 106 . After the assembly of complex A, the U4-U6 and U5 snRNPs are recruited as a preassembled trisnRNP to form complex B, in a reaction catalysed by the DExD/H helicase Prp28. The resulting complex B goes through a series of compositional and conformational rearrangements to form a catalytically active complex B (complex B*). Multiple RNA helicases (Brr2, 114 kDa U5 small nuclear ribonucleoprotein component (Snu114) and Prp2) are required for the activation of complex B, resulting in rearrangements that lead to the formation of the U2-U6 snRNA structure that catalyses the splicing reaction 107 . The activation of complex B also unwinds the U4 and U6 snRNAs, releasing U4 and U1 from the complex 108 , which is thought to unmask the 5ʹ end of U6 snRNA.
Complex B* then completes the first catalytic step of splicing, generating complex C, which contains the free exon 1 and the intron-exon 2 lariat inter mediate (FIG. 4a) . Complex C undergoes additional ATPdependent re arrangements before carrying out the second catalytic step of splicing, which is dependent on Prp8, Prp16 and synthetic lethal with U5 snRNA 7 (Slu7); this results in a post-spliceosomal complex that contains the lariat intron and spliced exons. Finally, the U2, U5 and U6 snRNPs are released from the mRNP particle and recycled for additional rounds of splicing. As with other spliceosomal rearrangement steps, release of the spliced product from the spliceosome is catalysed by the DExD/H helicase Prp22 (REFS 109, 110) . Disassembly of the post-catalytic spliceosome is also driven by several RNA helicases (for example, Brr2, Snu114, Prp22 and Prp43) in an ATP-dependent manner 111 . Single-molecule analyses have provided additional insights into the process of spliceosome assembly. Fluorescence labelling has been used to visualize how individual spliceosomal subcomplexes sequentially associate with the pre-mRNA to generate functional spliceosomes 112, 113 . Using purified components, these in vitro studies have shown that all of the major spliceosomal assembly steps are reversible 113 , including the catalytic splicing steps 114 . This reversibility, especially of the early steps, implies that proofreading occurs during splicing 115 . Commitment to splicing is thought to increase as spliceosome assembly proceeds in vitro 113 , consistent with the idea of a reversible stage during which partially assembled spliceosomes retain the capacity to disassemble and reassemble onto an alternative splice site. Whether splicing can be reversed in vivo is unclear, and additional studies will be required to address this point.
Figure 4 |
Step-wise assembly of the spliceosome and catalytic steps of splicing. Spliceosome assembly takes place at sites of transcription. a | The U1 and U2 small nuclear ribonucleoproteins (snRNPs) assemble onto the pre-mRNA in a co-transcriptional manner through recognition of the 5ʹ splice site (5ʹss) and 3ʹss, which is mediated by the carboxy-terminal domain (CTD) of polymerase II (Pol II). The U1 and U2 snRNPs interact with each other to form the pre-spliceosome (complex A). This process is dependent on DExD/H helicases pre-mRNA-processing 5 (Prp5) and Sub2. In a subsequent reaction catalysed by Prp28, the preassembled tri-snRNP U4-U6•U5 is recruited to form complex B. The resulting complex B undergoes a series of rearrangements to form a catalytically active complex B (complex B*), which requires multiple RNA helicases (Brr2, 114 kDa U5 small nuclear ribonucleoprotein component (Snu114) and Prp2) and results in the release of U4 and U1 snRNPs. Complex B* then carries out the first catalytic step of splicing, generating complex C, which contains free exon 1 (Ex1) and the intron-exon 2 lariat intermediate. Complex C undergoes additional rearrangements and then carries out the second catalytic step, resulting in a post-spliceosomal complex that contains the lariat intron and spliced exons. Finally, the U2, U5 and U6 snRNPs are released from the mRNP particle and recycled for additional rounds of splicing (dashed arrow). Release of the spliced product from the spliceosome is catalysed by the DExD/H helicase Prp22 (REFS 109, 110) . b | During splicing, RNA-RNA interactions are rearranged in a stepwise manner to create the catalytic centre of the spliceosome. Initially, U1 and U2 small nuclear RNA (snRNA) pair with the 5ʹss and the branch point sequence within complex A (the branch point adenosine is indicated by the letter A). Subsequently, complex A associates with the U4-U6•U5 tri-snRNP, leading to new base pairs between U2 and U6 snRNA and between U5 snRNA and exonic sequences near the 5ʹss. The U4 snRNA is disassociated from U6 to expose the 5ʹ end of U6, which then base pairs with the 5ʹss to displace U1 snRNA. In the end, an extensive network of base-pairing interactions is formed between U6 and U2, juxtaposing the 5ʹss and branch-point adenosine for the first catalytic step of splicing. The central region of U6 snRNA forms an intramolecular stem-loop (the U6-ISL), which is essential for splicing catalysis. pA, polyA signal.
Aside from the traditional pathway of spliceosome assembly, at least two alternative models have been proposed. In one model, spliceosome assembly does not strictly depend on a pre-mRNA substrate, and the mRNA 5ʹss can be recognized by the U1 snRNP within a penta-snRNP complex containing all five snRNPs 116, 117 . However, this penta-snRNP observed in vitro has not been supported by studies of co-transcriptional spliceosome assembly 118 , and most of the evidence indicates that initial spliceosome assembly requires the presence of a 5ʹss in the pre-mRNA substrate 119 . In the other alternative model, the U4-U6•U5 tri-snRNP can be recruited to the exon definition complex, which then can be transformed directly into a cross-intron B-like complex withou t prior formation of a cross-intron complex A 120 .
Splicing is catalysed by RNA. The spliceosome is a dynamic complex the components of which undergo multiple conformational and compositional changes during the splicing reaction. Rearrangements occur between snRNA s, spliceosomal proteins and the premRNA substrate, and are required in order to generate an activated spliceosome. The snRNAs, rather than the spliceosomal proteins, are believed to provide the catalytic activity. Previous genetic and biochemical studies have established that snRNAs and substrate pre-mRNA undergo a series of dynamic base-pairing rearrangements to achieve catalysis (reviewed in REF. 121 ). More recently, it was shown that the two-step splicing reaction (that is, the exchange of phosphodiester bonds) could be catalysed in a protein-free system by a U6-U2 snRNA complex that resembles a self-splicing ribozyme 122, 123 . Indeed, structural analyses have provided information regarding atomic events within the catalytic core of the spliceosome during distinct stages of the splicing reaction 124 . We provide a brief overview below of how the active structure of the catalytic site is generated via RNA rearrangement (see REFS 4, 93, 121 for more detailed reviews).
During the early stages of spliceosomal assembly, U1 snRNA base pairs with the 5ʹss. Meanwhile, U2 snRNA pairs with the branch point sequence, forming a short duplex that causes the branch-point adenosine to bulge out and present its 2ʹ hydroxyl group as a nucleophile (FIG. 4b) . Within complex A, interactions between U1 and U2 snRNPs bring the 5ʹss, the branch point and 3ʹss into close proximity. Subsequently, complex A associates with the U4-U6•U5 tri-snRNP (TABLE 1) . Recruitment of this tri-snRNP complex displaces the extensive base pairing between the U4 and U6 snRNAs and leads to the formation of new base pairs between U2 and U6 107 (FIG. 4b) .
During this process, dissociation of U4 from U6 snRNA exposes the 5ʹ end of U6, which then base pairs with the 5ʹss, displacing U1 snRNA (FIG. 4b) .
An extensive network of base pairs is thus formed between U6 and U2 snRNA, which juxtaposes the 5ʹss and the branch-point adenosine for the first catalytic step of splicing. The central region of U6 snRNA forms an intramolecular stem-loop (the U6-ISL), which is key for splicing catalysis. Recruitment of the U4-U6•U5 trisnRNP also triggers U5 snRNA interaction with exonic sequences located near the 5ʹss. This interaction is probably essential for anchoring exon 1 in proximity to the exon 2 lariat in preparation for the second catalytic step of splicing (FIG. 4) . During these dynamic rearrangements, the U2-U6 complex (FIG. 4b) is thought to be the active structure that catalyses both steps of the splicing reaction. This complex shares several common structural features with the group II self-splicing introns that are found in ribozymes [124] [125] [126] , suggesting that spliceosomal catalysis might be mechanistically similar to that of ribozymes 127 . In addition to base pairing among and between the snRNAs, divalent cations (for example, Mg 2+ ) are required for pre-mRNA splicing 128 . These metal ions might directly participate in the catalytic reactions and/ or help to maintain the active RNA conformation 93 . Using a 'metal rescue' strategy, U6 snRNA was shown to position the divalent metal ions to catalyse both steps of splicing by stabilizing the leaving groups 127 . The energy requirement for both catalytic steps of splicing is minimal, but a large amount of energy is devoted to RNA remodelling of the snRNAs. Spliceosomal remodelling is primarily catalysed by multi ple DExD/H RNA helicase/ ATPase 129 and elongation facto r G (EF-G)-like GTPase 130 proteins. Certain spliceosomal proteins may also improve the efficiency of splicing by stabilizing the RNA active site in vivo. For example, Prp8 is closely associated with the catalytic core of the spliceosome 131 and is required for both its catalytic steps 132 . The Brr2 helicase unwinds U4-U6 snRNAs to allow U6 to pair with U2 and form the catalytically active structure. Moreover, the C-terminal tail of Prp8 can interact with Brr2 and inhibit this process 133 , suggesting that alternating interactions between snRNAs and proteins regulate spliceosomal activation. The second catalytic step of splicing is also thought to be promoted by proteins, including Prp16, Prp18 and Slu7. Notably, the ATP-dependent activity of Prp16 is sufficient to activate complex C for the second catalytic step of splicing 134 .
Splicing regulation
Most genes in higher eukaryotes undergo alternative splicing to produce multiple isoforms with distinct activities. The spliceosome is responsible for directing both constitutive and alternative splicing, and regulation of its assembly is a key control point in these processes. Alternative splicing is tightly controlled in different tissues at distinct developmental stages, and the dysregulation of splicing is associated with several human diseases
. Human introns are several to hundreds of kilobases in length (~5 kb on average) and contain numerous 'decoy' splice sites (that is, sequences that have a similar degree of consensus matching to authentic sites). A pair of decoy splice sites often form pseudo-exons that resemble authentic exons in terms of length and splice site strength but are very rarely, if ever, spliced 135 . So, despite these prevalent decoy sites, the splicing process occurs with high fidelity, suggesting that additional sequence features aside from core splicin g signals contribute to exon-intron definition.
Cis-acting elements regulate splicing. Alternative splicing is typically controlled by numerous cis-regulatory RNA elements that serve as either splicing enhancers or silencers. On the basis of their locations and activities, these splicing regulatory elements (SREs) are classified as exonic splicing enhancers (ESEs), intronic splicing enhancers (ISEs), exonic splicing silencers (ESSs) or intronic splicing silencers (ISSs). Although the activities of SREs are often context dependent (FIG. 5a) , these sequences generally function by recruiting trans-acting splicing factors that activate or suppress different steps of the splicing reaction 136, 137 . How splicing factors affect splicing decisions has been a topic of extensive research. Many splicing factors are auxiliary proteins of the spliceosome and interact with its core components to regulate splicing 5, [138] [139] [140] . Most known splicing factors control splicing by affecting the early and intermediate steps of spliceosomal assembly: formation of the exon definition complex and the subsequent transition to the intron-spanning complex A. A well-studied example is the protein polypyrimidine tract-binding (PTB), which typically inhibits splicing by binding to short polypyrimidine-rich elements in premRNAs. When binding to exons, PTB can cause exon skipping by recognizing an ESS and inhibiting formation of the exon definition complex 141 . PTB can also inhibit splicing by affecting the transition from an exon definition complex to an intron definition complex 106 , and can directly interact with U1 snRNP to prevent its interaction with other spliceosomal components 142 (FIG. 5a) . Similarly, the splicing factor RNA-binding motif 5 (RBM5) interacts with a U2 snRNP component (U2AF65) and inhibits the transition from an exon definition to an intron definition complex 105 . In addition, hnRNP L and hnRNP A1 induce extended contacts between U1 snRNA at the 5ʹss and neighbouring exonic sequences that, in turn, inhibit stable association of U6 snRNA and subsequent spliceosomal catalysis 143 . In addition to the early steps of spliceosomal assembly, an alternative exon in the CD45 (also known as PTPRC) mRNA was found to be inhibited after ATP-dependent exon recognition 144 , suggesting that alternative splicing Cus1, cold-sensitive U2 snRNA suppressor 1; Lea1, looks exceptionally like U2A 1; Lsm, Sm-like; Msl, Male-specific lethal homologue; nt, nucleotides; Prp, premRNA-processing; Rds3, regulator of drug sensitivity 3; Rse1, RNA splicing and ER to Golgi transport factor 1; Sad1, snRNP assembly-defective 1; SF, splicing factor; Spp2, suppressor of PRP; snRNA, small nuclear RNA; snRNP, small nuclear ribonucleoprotein; Snu, U5 small nuclear ribonucleoprotein component; U2AF, U2 auxiliary factor; Urn1, U2-U5-U6 snRNP, RES complex and NTC-interacting pre-mRNA-splicing factor 1. *The protein composition is primarily based on a mass spectrometric analysis of the yeast spliceosome 203 ; certain regulatory factors that are closely associated with the core spliceosome (such as SR proteins) are not included. Proteins are listed using the budding yeast nomenclature unless there is no known yeast homologue. In certain cases, the common name of a metazoan homologue is also included in brackets. ‡ The snRNA lengths are based on yeast transcripts. can be regulated at many points along the spliceosomal assembly pathway.
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The activities of SREs often depend on their relative locations within pre-mRNAs (FIG. 5b) . This context dependence highlights the flexiblity of the interactions of the splicing regulatory factors with the core splicing machinery. Given the complexities of spliceosomes, it is not surprising that the effects of splicing factors on core spliceosomal components might vary, depending on their relative positions on the pre-mRNA. For example, oligo-G tracts commonly enhance splicing from intronic locations by recruiting hnRNP H 145, 146 , but these same elements can inhibit splicing when located in exons 147, 148 (FIG. 5b) . The underlying mechanism for such activities may involve inhibition of the exon definition complex by hnRNP H 'across' the site of binding. Similarly, the YCAY motifs that are recognized by the neuro-oncological ventral antigen (NOVA) family of neuron-specific splicing factors can function as ESEs, ISEs or ISSs, depending on their positions relative to the regulated exon 149 (FIG. 5b) . SR proteins usually promote splicing when bound to exons, but they can inhibit splicing when associated with introns 150 . Moreover, hnRNP A1 can inhibit splicing from either exonic or intronic locations 150 (FIG. 5b) . Notable exceptions to these rules have also been observed. For example, the Drosophila melanogaster orthologues of hnRNP A1 can enhance splicing from an intron 151 . U1 snRNPs can also suppress splicing or inhibit polyadenylation by interacting with 5ʹss-like RNA elements. In an unbiased screen, sequences resembling 5ʹ splice sites were identified as ESSs that inhibit exon inclusion 152 . The binding kinetics between U1 snRNP and the 5ʹss can also affect alternative splice site choice, independently of the activities of other splicing factors 153 . Non-conventional functions of U1 snRNPs in preventing premature mRNA cleavage and polyadenylatio n are discussed in greater detail in BOX 2.
Other influences on splicing. The accessibility of splice sites or cis-acting SREs can be influenced by pre-mRNA structures and binding proteins. For example, a stemloop sequence located at the 5ʹss of exon 10 of the human TAU (also known as MAPT) gene directly affects the use of the 5ʹss. Stabilization of this stem-loop decreases exon 10 inclusion and, reciprocally, its destabilization increases exon 10 inclusion 154 . Another example is the Down syndrome cell adhesion molecule-like (Dscam) gene in D. melanogaster, in which the secondary structure of the intron ensures mutually exclusive splicing of alternative exons [155] [156] [157] . It is unclear whether examples like this are unusual cases or whether they are the general rule. Spliceosomes contain multiple DExD/H RNA helicases that can unwind RNA structures and remodel RNA-protein complexes 158 . Although the primary function of these helicases seems to be the rearrangement of snRNA-snRNA and snRNA-protein interactions in the spliceosome, at least one helicase (DEAD box 17 (DDX17; also known as p72)) might be able to remodel pre-mRNA structures, thus modulating alternative splicing 159, 160 . General roles for RNA structures in splicing regulation have yet to be clearly defined, and the identification of such elements by high-throughput methods should prove very useful 161 . Because splicing of most introns happens co-transcriptionally 162 , alternative splicing is also affected by factors that control transcription initiation and elongation. For example, the rate of transcription elongation can affect splicing events; slow elongation rates generally promote the inclusion of weak exons 163, 164 . In addition, alternative splicing may be affected by chromatin structure and nucleosome positioning. A large number of recent reports have provided interesting insights into the connections between splicing and transcription (for further details, see REFS 165, 166 ).
An integrated code for splicing regulation. Traditional models of splicing regulation typically consider the interaction between cis-acting SREs and their cognate factors as a one-to-one relationship. However, most splicing factors can recognize two or more SRE motifs, and each SRE motif is bound by multiple alternative factors, supporting the idea that a complex network of protein-RNA interactions is responsible for splicing regulation 150, 167 . This pattern of overlapping binding specificities may enable a variety of regulatory relationships between splicing regulators. Multiple proteins with similar splicing regulatory activities might bind the same motif, resulting in functional redundancy; alternatively, one factor might displace another factor with opposite activity to confer functional antagonism. For example, in HeLa cells, neuronal PTB (nPTB) can compensate for depletion of PTB 168 , whereas during neural development replacement of PTB by nPTB is thought to initiate an alternative splicing programme 169 . RNA-binding factors with overlapping specificities may also provide subtle fine-tuning of splicing levels. Importantly, the densely connected network of SREs and their cognate splicing factors suggests that individual exons are often controlled by multiple factors to achieve regulatory plasticity. To assemble a set of splicing regulatory rules (known as the 'splicing code'), computational models have been applied to integrate the actions of multiple splicing factors and SREs, thereby allowing splicing outcomes to be predicted from sequence informatio n in the pre-mRNA 152, 170 .
Conclusions and perspectives
A major challenge in the post-genomic age of molecular biology is to understand how a limited number of human genes can generate a proteome that has five times the number of proteins 171 . The spliceosome, which reads the information for splicing each pre-mRNA transcript, is probably the most complicated RNA-protein complex inside the eukaryotic cell 172 . Although important insights have been obtained during the past decade, there are still many unanswered questions about the bio genesis of this macromolecular machine. For example, the signalling factors that regulate snRNP biogenesis are poorly understood, as are the functions of many post-translation al modifications of snRNP proteins. Moreover, a key question is how conformational and compositional changes within the spliceosome dictate splicing outcomes. Detailed studies of spliceosome dynamics should provid e much-needed answers.
Another important research goal is to understand the 'splicing code' by which exon inclusion or exclusion by the spliceosome is controlled in different tissues and cell types 170 . Recent advances in functional genomics have
Box 2 | The unusual activities of U1 snRNP
In addition to its function in the spliceosome, U1 small nuclear ribonucleoprotein (snRNP) has roles in RNA processing. As a core component of the spliceosome, U1 regulates splicing in a similar manner to that of auxiliary splicing factors, usually inhibiting splicing by binding to the 5ʹ splice site (5ʹss)-like elements, which were identified as exonic splicing silencers in an unbiased screen 152 . For example, a 5ʹss-like sequence in an intron of the ataxia telangiectasia mutated (ATM) gene inhibits pseudo-exon splicing by recruiting U1 snRNP, and a mutation of this sequence causes ataxia telangiectasia [188] [189] [190] . In addition to regulating splicing, the U1 snRNP also controls other RNA-processing pathways, such as polyadenylation 191, 192 . Using genome-wide analysis methods, U1 snRNP was found to protect premature RNA cleavage and polyadenylation at alternative polyadenylation sites in primary transcripts [193] [194] [195] . In certain cases, the recruitment of a single U1 snRNP component (U1A) affected selection of the alternative polyadenylation site 196, 197 . The precise mechanism by which U1 snRNP affects polyadenylation is not clear. Current models suggest that U1 may inhibit the cleavage or polyadenylation site or may affect recognition of the polyadenylation signal by the cleavage and polyadenylation specificity factor (CPSF), a protein complex that cleaves mRNA at the 3ʹ end to facilitate subsequent polyadenylation 198 . Another twist in U1 snRNP function is found during trans-splicing in lower eukaryotes, when a spliced leader RNA (slRNA) forms a U1 snRNP-like complex that interacts with other snRNPs to direct the splicing of slRNA onto pre-mRNAs. In such cases, the slRNP complex has a dual function and acts in the same way with complex E, which contains both U1 snRNP and pre-mRNA. Similarly to other snRNPs, the maturation of slRNP also requires the survival motor neuron complex and involves both nuclear and cytoplasmic events 199 , and the mature slRNP will subsequently interact with U2, U4, U5 and U6 snRNP to form the trans-spliceosome. This form of splicing is found in almost all genes in Trypanosoma brucei and Caenorhabditis elegans, but can be found only at a very low frequency in mammalian cells 200 . Interestingly, an artificial 'half exon' can be forced to trans-splice onto a normal human pre-mRNA with reasonable efficiency 201 , suggesting that trans-splicing probably uses a similar spliceosomal assembly pathway to direct the splicing reaction. fuelled identification of the myriad regulatory elements and splicing factors involved, providing the research community with a near-complete 'parts list' of the splicing regulatory machinery. Integration of this information should help to determine the mechanism by which the splicing code is read by the spliceosome and ultimately provide a better understanding of complicate d gene expression networks.
